Delivery Order SPE2DB20D7061-SPE2DB25FSNZ2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,087.30 to AmerisourceBergen Drug Corp for the supply of Cephalexin 500 mg capsules (500-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a fulfillment under AmerisourceBergen's existing Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,314,953 units of Cephalexin 500 mg capsules. The contract has a firm fixed price of $4,979.51 and a performance period that runs through August 2, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Cephalexin 250 mg capsules in quantities of 500 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,456.96 and is scheduled for completion by August 11, 2025. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and...
- The Defense Logistics Agency awarded a delivery order valued at approximately $643 to Amerisourcebergen Drug Corporation for the supply of 40 capsules of 500mg Cephalexin. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by August 23, 2023. Amerisourcebergen will serve as the prime contractor, with performance taking place under a firm fixed price contract. No major subcontractors or set aside designations were indicated. The Defense...
- The Defense Logistics Agency awarded a $178,760 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 capsules of 500mg Cephalexin antibiotics. The contract has a period of performance from June 29, 2023 through June 30, 2023, with all products to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the U.S....
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $1,789.64, is for the delivery of 4,563,942,071 units of the pharmaceutical product Cephalexin 250 mg/5 ml suspension in 100 ml containers. This delivery order does not have a set-aside designation. The award is part of a larger, single-award indefinite...
- The Defense Logistics Agency Troop Support Medical awarded a $4,088.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200mL of the pharmaceutical product Cephalexin 250 mg/5 mL suspension. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 7-10, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the antibiotic Cephalexin from the DLA...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,755.14, is for the delivery of 4,563,750 units of 250 mg Cephalexin capsules. This is a firm fixed-price delivery order contract with a completion date of February 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $572 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 capsules of 500mg cephalexin antibiotics. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 11, 2023 in support of DLA programs. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the US military and this order for common antibiotics...
- The Defense Logistics Agency awarded a $1,562.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 capsules of 500mg cephalexin antibiotic. The order was placed under an existing prime vendor contract vehicle to support DLA pharmaceutical procurement needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from September 1st through September 5th, 2023. No subcontractors or set aside...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSNZ2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,609.79 to AmerisourceBergen Drug Corp for 500 mg Cephalexin capsules (500-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the Defense Health Agency's medical supply chain. As a major prime vendor, the company supplies a comprehensive range of pharmaceuticals and medical commodities to support military and veteran healthcare systems globally. The Cephalexin antibiotic procurement reflects the company's ongoing responsibility to fulfill routine medical supply requirements across the federal healthcare network through the DLA's global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/22/25 |